Bremen, November 5, 2007 - MeVis Medical Solutions Aktiengesellschaft, together with the syndicate banks M.M.Warburg & CO (Lead Manager / Bookrunner) and Landesbank Baden-Württemberg (Co-Lead Manager), today have fixed the price range within which investors can bid in the context of the planned IPO for the up to 776.866 shares in the company, at EUR 55.00 to EUR 65.00 per share. The offering period starts on November 7, 2007 and will end on November 14, 2007 at 11:00 (CET) for private investors and at 13:00 (CET) for institutional investors. All further terms and conditions of the offering are contained in the approved prospectus available for download at www.mevis.de.
Additional information:
ISIN: DE000A0LBFE4
WKN: AOLBFE
Admission applied for: Prime Standard segment; Frankfurt Stock Exchange